ANTISENSE OLIGONUCLEOTIDE-BASED ANTI-FIBROTIC THERAPEUTICS Application WO-2024050261-A1 World Intellectual Property Organisation (WIPO) 07 Mar 2024
ANTISENSE OLIGONUCLEOTIDES FOR MODIFYING PROTEIN EXPRESSION Application WO-2023086295-A3 World Intellectual Property Organisation (WIPO) 22 Jun 2023
COMPOSITIONS AND METHODS FOR INCREASING EXPRESSION OF SCN2A Application EP-3740500-A4 European Patent Office 19 Jan 2022